ATLASKairos Pharma (KAPA) earnings date: Nov 13, 2026
Kairos Pharma (KAPA) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026. Analysts expect EPS of -$0.63.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on KAPA
| Last price | $0.52 (-1.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±7.0% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 3 reports |
These figures come from the same calibrated model and valuation as the Kairos Pharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Kairos Pharma reports on Nov 13, 2026. One email the day before, with ATLAS’s read on Kairos Pharma. You can switch it off at any time.
Alert me before KAPA reportsFree to start. Creating an account takes under a minute.
Notify me when Kairos Pharma reports
Track KAPA free Add Kairos Pharma to a free ATLAS watchlist and see its next report date in one place.
KAPA earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.63 |
| Last report | Aug 12, 2026 · Beat |
| Beat rate (last 3 reports) | 2 of 3 (67%) |
| Average EPS surprise | +20.1% |
| Average move around a report | ±6.8% (last 3) |
| Sector | Healthcare · Biotechnology |
Kairos Pharma earnings history: last 3 reports
Kairos Pharma last reported on Aug 12, 2026: EPS of -$0.42 against an estimate of -$0.63 (+33.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$0.63 | -$0.42 | +33.3% | Beat | -0.8% |
| Jun 10, 2026 | $0.43 | $0.43 | 0.0% | In line | +6.3% |
| May 11, 2026 | $0.41 | $0.52 | +26.8% | Beat | -13.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for KAPA
See the fair value, the probability range and the earnings history of Kairos Pharma on its ATLAS page.
Kairos Pharma (KAPA) stock analysisPlans from €3.99 a month.
Kairos Pharma earnings: frequently asked questions
When does Kairos Pharma (KAPA) report earnings?
Kairos Pharma is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for KAPA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.63 per share (USD). Estimates can change before the report.
How often does KAPA beat earnings estimates?
Of its last 3 reports with a recorded result, Kairos Pharma beat the EPS estimate 2 times; the average surprise was +20.1%. Past results do not predict the next one.
How much does KAPA move around earnings?
Over its last 3 reports the stock moved an average of 6.8% (absolute, from the close before the report day to the close after it), and finished higher 1 of 3 times.
Did Kairos Pharma beat earnings estimates last quarter?
Kairos Pharma last reported on Aug 12, 2026: EPS of -$0.42 against an estimate of -$0.63 (+33.3% surprise), a beat.
How much does KAPA usually move in a day?
On a normal trading day the ATLAS model puts KAPA’s one-day range at about ±7.0%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer